Sentences with phrase «corporate share of revenue»

In the 50's and 60's, high corporate tax rates and a large corporate share of revenue from income taxes were fine because the rest of the world was devastated from war.

Not exact matches

People want free markets — and the free flow of goods and services across borders — but they don't want to be told that other places are better places to do business, and they don't like the idea that another nation might grab a bigger share of corporate tax revenues.

The Corporate Cupcake After a slightly uneasy night's sleep (I had overdone it that evening at Baked & Wired, a well - entrenched Georgetown cupcake establishment), I start the first full day of my trip at Crumbs Bake Shop in downtown D.C. Crumbs is the nation's largest cupcake company, with 35 locations and $ 31 million in annual revenue, and also the most corporate, with plans to trade shares on the Nasdaq startinCorporate Cupcake After a slightly uneasy night's sleep (I had overdone it that evening at Baked & Wired, a well - entrenched Georgetown cupcake establishment), I start the first full day of my trip at Crumbs Bake Shop in downtown D.C. Crumbs is the nation's largest cupcake company, with 35 locations and $ 31 million in annual revenue, and also the most corporate, with plans to trade shares on the Nasdaq startincorporate, with plans to trade shares on the Nasdaq starting in May.

And the follow - through into corporate earnings and, importantly, revenue growth certainly was supportive of share prices.

Earlier this week, Bank of America Merrill Lynch said the new tax legislation would boost business - travel spending this year and that would help boost shares of Delta, United and American, which are heavily reliant on corporate travel revenue.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

Between 1980 and 2012, the share of federal revenue derived from corporate tax revenue fell to 13.6 % from 15.2 %.

Emerging economies account for a larger share of global GDP, corporate revenues, and profits than is reflected in the market capitalization of global equity markets.

While the current price / peak - earnings multiple is already at an elevated level above 18, what I'll call the «P / E equivalent» multiples on other fundamentals are: 21 on the basis of book values, nearly 23 on the basis of enterprise value / EBITDA (which factors in the increasing share of debt on corporate balance sheets), over 25 on the basis of revenues, and 29 on the basis of dividends (largely because dividend payout ratios remain relatively low even on the basis of normalized earnings).

In other words, corporate income tax revenues as a share of federal government revenues are on track to rise by 15 per cent in five years.

The speculation is that as some of RIM's large corporate clients start scaling back BlackBerry purchases and upgrades as the economic downturn takes hold, hurting directly the co's performance and its revenues — RIM shares will further deteriorate, consequently loosing more value.

«If they were at the same 21 percent share of corporate profits as they had averaged in the two decades before these cuts, the federal government would have about $ 25 billion more in corporate tax revenues annually.

  In fact, as a share of our economy and of corporate profits, federal tax corporate tax revenues were 31 and 30 percent lower respectively last year than they were in 2007/8.

In fact, as a share of our economy and of corporate profits, federal tax corporate tax revenues were 31 and 30 percent lower respectively last year than they were in 2007/8.

Federal corporate tax revenues are expected to rise in coming years, but will remain well below the shares of corporate profits and the proportion of the economy they had been prior to these tax cuts.

Still, all thirteen of the countries with higher corporate tax revenues as a share of GDP than the U.S. have lower corporate tax rates.

A fair budget would also freeze tax breaks for big businesses and close corporate tax loopholes so corporations pay their fair share of State revenue».

But again we are primarily interested in the portion of that gross consumer spend that actually goes to authors in the form of ebook royalties or ebook revenue share, rather than the portion that is dissipated on publisher corporate overhead.

Expert analysis published several years ago by Resources for the Future (which we summarize and link to on our Tax Shifting page) suggested that using carbon tax revenue to reduce corporate income tax rates would benefit middle - and upper - income households but not lower - income families, relatively few of whom own stocks whose share values would rise as corporate tax rates were reduced.

Partnering with VP of Sales and Director of Sales to exceed overall market share and sales objectives across a 5 - state territory as the Territory Manager for MarketNet (2005 - 2014); consistently outperforming corporate sales and revenue goals through the development of aggressive and successful business initiatives and effective promotional plans.

PROFESSIONAL EXPERIENCE PNC BANK, Evanston, IL (6/2012 to Present) Branch Manager • Determine the branch's market share and optimize growth in sales and profits • Develop client relationships by ensuring that relationship managers are performing their work properly • Work closely with bank management and sales teams to determine sales targets • Ascertain that bank staff is aware of sales targets and perform reviews towards these goals • Manage branch operations and motivate staff members to strive and exceed sales goals • Develop forecasts and financial objectives and ensure that staff members are in sync with them • Locate areas for improvement and propose corrective measures • Meet with corporate clients to determine their needs and ensure that they are fulfilled immediately • Address both client and staff issues promptly and ensure that they are resolved • Handle networking and marketing duties to make sure that the bank's revenue and sales goals are met constantly

Top - producing sales resource with a successful track record of rapidly establishing new geographic markets, increasing market share and, driving revenue growth, skilled negotiator with a track record of forging corporate level strategic partnerships that drive business growth and, revenues, works comfortably in strategic selling positions; from initial prospecting to closing and follow - up, effective communicator that utiliz...